New generation multi-modal antidepressants: focus on vortioxetine for major depressive disorder
نویسندگان
چکیده
Vortioxetine is a novel antidepressant with effects on multiple 5-HT receptors and on the serotonin transporter. This paper reviews preclinical and clinical evidence regarding its mechanism of action, its tolerability, and its efficacy in treating major depression. Clinical studies indicate that vortioxetine is effective in the treatment of major depression, though there is no suggestion of superiority over active comparators. There may be a clinically meaningful advantage in terms of tolerability.
منابع مشابه
Vortioxetine (Brintellix®): A Review
Volume 29 Issue 6 March 2014 1 ajor depressive disorder (MDD) is a common and prevailing mental disorder that affects an individual’s overall health, quality of life and productivity. The annual and lifetime prevalence of MDD in United States is 6.7% and 16.5% of the adult population, respectively, and 50% to 80% will experience another depressive episode.1,2 MDD also carries a signi icant econ...
متن کاملLevomilnacipran and vortioxetine: Review of new pharmacotherapies for major depressive disorder
Major depressive disorder (MDD) is a common psychiatric disorder with an estimated lifetime prevalence rate in the range of 13% to 16% in the United States population. Patients with MDD often have symptoms such as depressed mood, loss of interest or pleasure in usual activities, changes in eating or sleeping patterns, fatigue, difficulty concentrating and thoughts of suicide. Although many phar...
متن کاملDrug interactions with vortioxetine, a new multimodal antidepressant.
This article summarized the available knowledge on clinically relevant drug interactions of vortioxetine, a new antidepressant with a “multimodal” serotonergic mechanism of action, recently approved for the treatment of major depressive disorder. Although information is still limited and mainly based on studies performed in healthy volunteers, vortioxetine appears to have a favorable drug inter...
متن کاملVortioxetine: a New Treatment for Major Depressive Disorder.
INTRODUCTION Vortioxetine is a structurally novel medication that has recently been approved for treatment of major depressive disorder (MDD). This medication is a serotonin reuptake inhibitor that also has a number of other potentially relevant effects on serotoninergic receptors, which may differentiate the drug's effects from those of current first-line antidepressants, such as selective ser...
متن کاملVortioxetine versus placebo for treatment of major depressive disorder
Introduction: Major depressive disorder is a common mental condition associated with substantial morbidity and economic burden. Approved by the FDA in September 2013 for treatment of episodes of major depressive disorder, Vortioxetine is one of the newer options available in this important area of therapeutics. Materials and methods: A comprehensive literature search (PubMed, the Cochrane libr...
متن کامل